Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Neoplasm
Interventions: OTHER: ctDNA level during neoadjuvant chemotherapy
Sponsor: Instituto Brasileiro de Controle do Cancer